MAPT and Alzheimer disease: In line with in vitro findings, icv STZ-animal models also showed changes in AD-related proteins, such as elevated Aβ and phosphorylated Tau (Ravelli et al. 2017; Salkovic-Petrisic et al. 2013, 2022).